Lior Zvi Braunstein, Melissa Mitchell, Hanna Bandos, William M. Sikov, Atif J. Khan, Peter Y. Chen, Patricia A. Ganz, Reshma Jagsi, Julia R. White, Reena S. Cecchini, Hyejoo Kang, Shannon L. Puhalla, Kelly L. Bolton, Eileen Connolly, Erica Michelle Stringer-Reasor, Kimberly Gergelis, Thomas B. Julian, Eleftherios P. Mamounas, Norman Wolmark. "A phase III randomized trial of radiotherapy optimization for low-risk HER2-positive breast cancer (HERO): NRG-BR008.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.tps1120